Search

The article presents a study which reviews available surveillance data source that identifies and tracks tobacco products as well as evaluates their strengths and weaknesses of possible data sources. It mentions that a responsive surveillance system is needed to identify and properly monitor tobacco products. It affirms that due to the absence of regulations that mandates the disclosure of product-specific data, public health officials are more likely to rely on imperfect data sources.

The article presents the result of the study which evaluates customer responses to potential reduced exposure tobacco products and look on how clinical methods can be used to assess such products. It mentions that the researchers utilized industry research data that focuses on product marketing and development. It also outlined model that conceptualizes the responses from customers, product perceptions and responses to product.

The article presents the result of the study which evaluates strategies used to assess potential reduced exposure products (PREP) for public health purposes. The researchers gathered primary data through records of research conducted by tobacco companies as well as manuscript drafts and presentations related to human tobacco use. It affirms that most of the clinical research has focused on reduced exposure products and asserts that the most widely used strategy is switching studies.

The article provides an assessment on the methods used for the evaluation of potential reduced exposure products (PREPs) to tobacco toxicants. It mentions that such evaluation process involves determining the effects of products on biomarkers of exposure and measuring the potential for abuse on the product. It also presents the strengths and limitations of the PREP method and review the risks associated with it.